TRUGLIF 25 MG TAB 14S

TRUGLIF 25MG Tablet contains Empagliflozin, an SGLT2 inhibitor used for the management of Type 2 Diabetes Mellitus. It lowers blood glucose by helping the kidneys remove excess sugar through urine. In addition to improving glycemic control, Empagliflozin has demonstrated cardiovascular and kidney protective benefits in eligible patients. Combined with a healthy diet, regular exercise, and routine blood glucose monitoring, TRUGLIF supports comprehensive diabetes management.

Uses

• Type 2 Diabetes Mellitus
• Blood glucose control
• Cardiovascular risk reduction in diabetic patients
• Kidney protection in eligible patients

Benefits

• Effectively lowers blood sugar
• Supports heart health
• Helps protect kidney function
• May assist with modest weight loss
• Convenient once-daily dosing

Possible Side Effects

• Frequent urination
• Urinary tract infections
• Genital fungal infections
• Increased thirst
• Dizziness

Pharmacist Advice
Stay well hydrated while taking this medicine. Monitor your blood glucose regularly and maintain good personal hygiene to reduce the risk of urinary and genital infections. Continue following your prescribed diabetic meal plan.